See All Slides - tctmd.com

Slides

Presentation TCT 2013

PCSK9 Inhibitors: Too Good to Be True?

Presenter: Evan Stein

October 30, 2013

Presentation TCT 2013

What Really Matters: Integrating Hard Endpoints (eg, Death, MI), Quality-of-Life Metrics, and Patient Preferences

Presenter: John Spertus

October 30, 2013

Presentation TCT 2013

Practical Aspects of FFR: Lesion Assessment and Tips and Tricks to Avoid Mistakes

Presenter: Michael Lim

October 30, 2013

Presentation TCT 2013

Flash Lecture #1: Renal Denervation: Basic Concepts, Physiological Rationale, Device Options and Procedure Steps

Presenter: Luciana Armaganijan

October 30, 2013

Presentation TCT 2013

The Effect of Tight Metabolic Control in Diabetic Patients Undergoing PCI

Presenter: Marco Wainstein

October 30, 2013

Presentation TCT 2013

Motion: The Envelope for TAVR Should be Expanded to All Candidates for Conventional AVR - Against: The TAVR Data are Only on High-Risk Patients with Limited Follow-Up

Presenter: Charles Davidson

October 30, 2013

Presentation TCT 2013

Translational Perspectives: Catheter-Based Mitral Intervention Therapies: Experimental Validation Pathways and Challenges

Presenter: Greg Kaluza

October 30, 2013

Presentation TCT 2013

Important Lessons from SIMPLICITY HTN-3 (Inclusion Criteria, Site Selection, and Study Endpoints): What I Would Do Differently Next Time?

Presenter: Deepak Bhatt

October 30, 2013

Presentation TCT 2013

Case #1 - Simultaneous Antegrade and Retrograde CTO Approach

Presenter: Pintoko Tedjokusumo

October 30, 2013

Presentation TCT 2013

SFA and Tibioperoneal Alternatives: Tailoring Therapeutic Choices

Presenter: Thomas Zeller

October 30, 2013

Advertisement

Slides

PCSK9 Inhibitors: Too Good to Be True?

What Really Matters: Integrating Hard Endpoints (eg, Death, MI), Quality-of-Life Metrics, and Patient Preferences

Practical Aspects of FFR: Lesion Assessment and Tips and Tricks to Avoid Mistakes

Flash Lecture #1: Renal Denervation: Basic Concepts, Physiological Rationale, Device Options and Procedure Steps

The Effect of Tight Metabolic Control in Diabetic Patients Undergoing PCI

Motion: The Envelope for TAVR Should be Expanded to All Candidates for Conventional AVR - Against: The TAVR Data are Only on High-Risk Patients with Limited Follow-Up

Translational Perspectives: Catheter-Based Mitral Intervention Therapies: Experimental Validation Pathways and Challenges

Important Lessons from SIMPLICITY HTN-3 (Inclusion Criteria, Site Selection, and Study Endpoints): What I Would Do Differently Next Time?

Case #1 - Simultaneous Antegrade and Retrograde CTO Approach

SFA and Tibioperoneal Alternatives: Tailoring Therapeutic Choices

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content